NTLA
Intellia Therapeutics Inc
12.30$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 161.4% | 201.4% | 216.1% | 263.1% | 238.9% | 317.5% | 301.2% | 305.7% | 313.7% | 252.8% | 227.3% | 229.0% | 259.2% | 290.2% | 268.3% | 232.3% | 178.9% | 579.7% | 609.4% | 899.0% | 839.6% | 553.6% | 1,182.9% | 642.9% | 728.6% | 737.0% | 770.4% | 848.0% | 19.1% | – | 8.7% | 37.4% | 1,198.3% | 907.9% | – | 565.3% | 572.8% | 26.1% | 14.6% | – | – | |
| -61.4% | -101.4% | -116.1% | -163.1% | -138.9% | -217.5% | -201.2% | -205.7% | -213.7% | -152.8% | -127.3% | -129.0% | -159.2% | -190.2% | -168.3% | -132.3% | -78.9% | -479.7% | -509.4% | -799.0% | -739.6% | -453.6% | -1,082.9% | -542.9% | -628.6% | -637.0% | -670.4% | -748.0% | 80.9% | – | 91.3% | 62.6% | -1,098.3% | -807.9% | 100.0% | -465.3% | -472.8% | 73.9% | 85.4% | 100.0% | -46.5% | |
| 161.4% | 201.4% | 216.1% | 263.1% | 238.9% | 317.5% | 301.2% | 305.7% | 313.7% | 252.8% | 227.3% | 229.0% | 259.2% | 290.2% | 268.3% | 232.3% | 178.9% | 579.7% | 609.4% | 899.0% | 839.6% | 553.6% | 1,182.9% | 642.9% | 728.6% | 737.0% | 770.4% | 848.0% | 948.1% | – | 377.9% | 1,604.3% | 1,354.2% | 907.9% | 652.1% | 681.2% | 687.5% | 385.2% | 536.5% | 1,078.4% | 582.7% | |
| 96.6% | 91.0% | 92.2% | 107.6% | 78.1% | 153.2% | 99.2% | 101.7% | 111.6% | 110.5% | 101.0% | 118.0% | 79.4% | 82.1% | 87.6% | 70.9% | 47.6% | 163.2% | 210.9% | 254.7% | 259.7% | 172.0% | 199.1% | 157.7% | 166.9% | 174.1% | 217.7% | 225.5% | 245.2% | – | 107.5% | 457.0% | 334.8% | 252.0% | 174.5% | 191.0% | 221.4% | 143.7% | 231.5% | 493.9% | 229.0% | |
| 258.1% | 292.3% | 308.3% | 370.7% | 317.0% | 470.7% | 400.3% | 407.3% | 425.3% | 363.3% | 328.2% | 347.0% | 338.6% | 82.1% | 87.6% | 70.9% | 47.6% | 163.2% | 210.9% | 254.7% | 259.7% | 172.0% | 199.1% | 157.7% | 166.9% | 174.1% | 217.7% | 225.5% | 1,174.2% | – | 485.3% | 2,061.2% | 490.7% | 252.0% | 826.6% | 306.8% | 336.0% | 502.7% | 753.4% | 1,572.3% | 665.2% | |
| -158.1% | -192.3% | -208.3% | -270.7% | -217.0% | -370.7% | -300.3% | -307.3% | -325.3% | -263.3% | -228.2% | -247.0% | -238.6% | -272.2% | -255.9% | -203.1% | -126.5% | -642.9% | -720.3% | -1,053.7% | -999.3% | -625.6% | -1,282.0% | -700.6% | -795.5% | -811.1% | -888.1% | -973.5% | -1,093.3% | – | -394.0% | -1,998.6% | -1,589.0% | -1,059.9% | -726.6% | -772.2% | -808.9% | -428.9% | -668.1% | -1,472.3% | -711.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | 9.6% | 3.9% | 1.2% | 3.1% | 3.4% | 3.2% | 4.8% | 3.9% | 3.7% | 5.0% | 14.7% | 39.4% | 70.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -153.7% | -187.7% | -203.2% | -263.5% | -209.9% | -359.4% | -285.9% | -289.4% | -306.5% | -242.0% | -210.3% | -231.0% | -222.6% | -258.6% | -246.3% | -199.2% | -125.3% | -639.8% | -716.9% | -1,050.5% | -994.5% | -632.0% | -1,305.3% | -717.6% | -853.5% | -835.5% | -818.1% | -909.8% | -1,019.2% | – | -371.3% | -2,112.6% | -1,489.5% | -1,001.2% | -687.6% | -710.8% | -735.2% | -416.2% | -639.5% | -1,392.3% | -672.2% | |
| 0.0% | -7.2% | 0.0% | 0.0% | 0.0% | -12.5% | 0.0% | 0.0% | 0.0% | -15.6% | – | – | – | – | – | – | – | -24.3% | – | – | – | -18.5% | -1.1% | -5.0% | 44.2% | 24.5% | -85.5% | -109.0% | -125.3% | – | 8.5% | – | – | – | – | – | – | – | – | – | – | |
| -153.7% | -187.7% | -203.2% | -263.5% | -209.9% | -359.4% | -285.9% | -289.4% | -306.5% | -242.0% | -210.3% | -231.0% | -222.6% | -258.6% | -246.3% | -199.2% | -125.3% | -639.8% | -716.9% | -1,050.5% | -994.5% | -632.0% | -1,305.3% | -717.6% | -853.5% | -835.5% | -818.1% | -909.8% | -1,019.2% | – | -371.3% | -2,112.6% | -1,489.5% | -1,001.2% | -687.6% | -710.8% | -735.2% | -416.2% | -639.5% | -1,392.3% | -672.2% | |
| -152.6% | -185.1% | -197.7% | -258.7% | -206.2% | -358.2% | -286.8% | -293.4% | -309.8% | -247.7% | -215.7% | -235.0% | -225.6% | -257.9% | -243.9% | -193.5% | -119.3% | -618.6% | -695.6% | -1,025.5% | -969.7% | -617.4% | -1,289.7% | -704.5% | -838.8% | -820.6% | -801.8% | -893.9% | -1,000.1% | – | -362.6% | -2,075.3% | -1,460.9% | -981.3% | -672.6% | -693.4% | -699.4% | -414.5% | -624.9% | -1,364.9% | -656.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.